Mammalian target of rapamycin inhibition as therapy for hematologic malignancies.
Cutler
Corey
C
Antin
Joseph H
JH
D019337:Hematologic Neoplasms / Q000188:drug therapy*; D006801:Humans; D011494:Protein Kinases / Q000627:therapeutic use*; D020123:Sirolimus / Q000037:antagonists & inhibitors*; D058570:TOR Serine-Threonine Kinases
D011494:Protein Kinases; C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases; D020123:Sirolimus